NovoCure Ownership | Who Owns NovoCure?
NovoCure Ownership Summary
NovoCure is owned by 52.67% institutional investors, 9.81% insiders, and 37.52% retail investors. Fmr is the largest institutional shareholder, holding 15.03% of NVCR shares. Fidelity Growth Compy Commingled Pl S is the top mutual fund, with 7.03% of its assets in NovoCure shares.
NVCR Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | NovoCure | 52.67% | 9.81% | 37.52% |
| Sector | Healthcare Stocks | 232.86% | 10.65% | -143.51% |
| Industry | Medical Instruments & Supplies Stocks | 32.32% | 13.56% | 54.11% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Fmr | 16.77M | 15.03% | $216.67M |
| Blackrock funding, inc. /de | 13.19M | 11.84% | $143.81M |
| Blackrock | 12.13M | 11.31% | $207.83M |
| Vanguard group | 10.96M | 9.79% | $141.69M |
| Soleus capital management | 8.53M | 7.62% | $110.30M |
| Morgan stanley | 5.07M | 4.53% | $65.55M |
| Wells fargo & company/mn | 2.95M | 2.65% | $32.17M |
| State street | 2.58M | 2.30% | $33.32B |
| Geode capital management | 2.48M | 2.21% | $32.03M |
| Balyasny asset management | 2.27M | 2.03% | $40.41M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Invus financial advisors | 350.88K | 6.74% | $6.01M |
| Soleus capital management | 8.53M | 4.07% | $110.30M |
| Palo alto investors lp | 1.26M | 3.00% | $16.23M |
| Sio capital management | 413.83K | 1.35% | $5.35M |
| Birchview capital, lp | 102.10K | 1.00% | $1.32M |
| Essex investment management | 452.37K | 0.78% | $4.93M |
| Bryce point capital | 48.98K | 0.77% | $632.76K |
| Corton capital | 13.62K | 0.43% | $175.93K |
| Washington capital management | 32.40K | 0.30% | $353.16K |
| Vestal point capital, lp | 400.00K | 0.23% | $5.17M |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Morgan stanley | 5.07M | 0.00% | 4.15M |
| Blackrock | 12.13M | 0.00% | 3.05M |
| Wells fargo & company/mn | 2.95M | 0.01% | 2.81M |
| Sg americas securities | 1.25M | 0.01% | 966.74K |
| Vanguard fiduciary trust | 712.77K | 0.00% | 712.77K |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Capital investors | - | - | -8.95M |
| Capital world investors | - | - | -2.00M |
| Soleus capital management | 8.53M | 4.07% | -1.11M |
| Marshall wace, llp | - | - | -1.03M |
| Deerfield management company, l.p. (series c) | - | - | -825.12K |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Vanguard fiduciary trust | 712.77K | 0.00% | 712.77K | $7.77M |
| Essex investment management | 452.37K | 0.78% | 452.37K | $4.93M |
| Schroder investment management group | 444.75K | 0.00% | 444.75K | $5.75B |
| Sio capital management | 413.83K | 1.35% | 413.83K | $5.35M |
| Vestal point capital, lp | 400.00K | 0.23% | 400.00K | $5.17M |
Sold Out
| Holder | Change |
|---|---|
| Total investment management | -1.00 |
| Turning point benefit group | -3.00 |
| Tfc financial management | -3.00 |
| Pfg private wealth management | -6.00 |
| Elyxium wealth | -10.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 31, 2025 | 158 | -39.23% | 58,941,636 | -35.77% | 52 | 0.78% | 88 | -35.77% | 41 | -46.75% |
| Sep 30, 2025 | 247 | 1.65% | 91,470,755 | -0.38% | 81 | 1.21% | 131 | 3.15% | 74 | 8.82% |
| Jun 30, 2025 | 247 | 4.22% | 94,464,090 | -0.79% | 84 | 1.14% | 129 | 16.22% | 71 | -8.97% |
| Mar 31, 2025 | 236 | -10.94% | 95,173,493 | 3.94% | 86 | 1.21% | 110 | -14.06% | 78 | 2.63% |
| Dec 31, 2024 | 249 | 5.51% | 88,494,339 | -4.72% | 81 | 1.11% | 117 | 27.17% | 74 | - |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| Fidelity Growth Compy Commingled Pl S | 8.14M | 7.03% | 11.33K |
| Fidelity Growth Compy Commingled Pl O | 7.46M | 6.89% | - |
| Fidelity Growth Company Fund | 5.54M | 4.78% | 128.63K |
| American Funds SMALLCAP World A | 4.75M | 4.26% | -3.59M |
| Vanguard US Total Market Shares ETF | 3.42M | 3.11% | 3.00K |
| American Funds Growth Fund of Amer A | 3.30M | 3.00% | -5.51K |
| Capital Group Growth Fnd of Amer Comp | 3.30M | 2.96% | -5.51K |
| Vanguard Total Stock Mkt Idx Inv | 3.36M | 2.95% | - |
| Vanguard Small Cap Index | 2.49M | 2.19% | 80.31K |
| iShares Russell 2000 ETF | 2.39M | 2.06% | 20.12K |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Mar 04, 2026 | Leupin Nicolas | Former Chief Medical Officer | Sell | $14.64K |
| Mar 04, 2026 | Weinberg Uri | Chf Medical and Innovation Ofr | Sell | $85.31K |
| Mar 04, 2026 | Brackmann Christoph | Chief Financial Officer | Sell | $85.31K |
| Mar 04, 2026 | Leonard Frank X | Chief Executive Officer | Sell | $74.60K |
| Mar 04, 2026 | Paravasthu Mukund | Chief Operating Officer | Sell | $71.54K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2026 Q2 | - | - |
| 2026 Q1 | - | 14 |
| 2025 Q4 | - | - |
| 2025 Q3 | 4 | - |
| 2025 Q2 | - | 12 |
NVCR Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools